Form 4: Sanuwave Health Executive Exercises and Acquires Options in Latest Filing
SEC Form 4
Peter Stegagno, Chief Operating Officer of Sanuwave Health, Inc., reports exercising warrants and acquiring stock options, resulting in changes to his beneficial ownership of the company's securities.
Summary
- Peter Stegagno, the Chief Operating Officer of Sanuwave Health, Inc., filed a Form 4 detailing changes in his beneficial ownership.
- On August 29, 2019, Stegagno exercised Class N warrants for 885 shares and Class O warrants for 1,141 shares of common stock at an exercise price of $0.00029 per share.
- He also acquired stock options on August 26, 2019, for 133 shares at an exercise price of $56.25 and on October 22, 2024, for 40,000 shares at an exercise price of $14.2.
- The filing also reflects the expiration and extension of various Class N and Class O warrants.
- All share amounts and exercise prices have been retroactively adjusted to reflect the 1-for-375 reverse stock split that occurred on October 18, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports transactions by an officer, which is a routine occurrence. The exercise of warrants could be seen as a positive sign, but the reverse stock split is a neutral to slightly negative indicator.
Positives
- The exercise of warrants indicates Stegagno's confidence in the company, as he converted them into common stock.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track changes in ownership and potential alignment of interests.
Comparison to Industry Standards
- Executive compensation packages often include stock options and warrants to align management's interests with those of shareholders, a common practice across publicly traded companies.
- Reverse stock splits are sometimes used by companies to increase their stock price to meet listing requirements or attract institutional investors; however, they can also be a sign of financial distress.
Stakeholder Impact
- The transactions reported in the Form 4 could influence investor sentiment regarding Sanuwave Health, Inc.
Key Dates
| Date | Description |
|---|---|
| 12/11/2017 | Reporting person received Class O Warrants exercisable for 1,141 shares of common stock at an exercise price of $0.00029 per share as compensation. |
| 12/21/2017 | Reporting person received Class N Warrants exercisable for 885 shares of common stock at an exercise price of $0.00029 per share as compensation. |
| 01/23/2019 | The Company extended the expiration date of the Class N Warrants to May 1, 2019. |
| 03/01/2019 | The Company extended the expiration date of the Class O Warrants to June 28, 2019. |
| 05/01/2019 | The Company extended the expiration date of the Class N Warrants to June 28, 2019. |
| 05/31/2019 | The Company extended the expiration date of the Class N Warrants to September 3, 2019. |
| 05/31/2019 | The Company extended the expiration date of the Class O Warrants to September 3, 2019. |
| 08/26/2019 | Reporting person acquired stock options for 133 shares at $56.25. |
| 08/29/2019 | Reporting person exercised Class N warrants for 885 shares of common stock at an exercise price of $0.00029 per share. |
| 08/29/2019 | Reporting person exercised Class O warrants for 1,141 shares of common stock at an exercise price of $0.00029 per share. |
| 10/18/2024 | 1-for-375 reverse stock split of the Company's common stock occurred. |
| 10/22/2024 | Reporting person acquired stock options for 40,000 shares at $14.2. |
| 04/07/2025 | Date of the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, SANUWAVE Health, Stock Options, Warrants, Peter Stegagno, SNWV
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.